Fisetin as an adjuvant treatment in prostate cancer patients receiving androgen-deprivation therapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Fisetin as an adjuvant treatment in prostate cancer patients receiving androgen-deprivation therapy

Published:2022-03 Issue:3 Volume:8 Page:
ISSN:2056-5623
Container-title:Future Science OA
language:en
Short-container-title:Future Science OA

Author:

Lorenzo Giuseppe Di¹²³,Scafuri Luca¹²,Costabile Ferdinando¹²,Pepe Liuba³,Scognamiglio Anna³,Crocetto Felice⁴,Guerra Germano³,Buonerba Carlo¹²

Affiliation:

1. Oncology Unit, Hospital ‘Andrea Tortora’, ASL Salerno, Pagani, Italy

2. Associazione O.R.A., Somma Vesuviana, Naples, Italy

3. Department of Medicine & Health Science, University of Molise, Campobasso, Italy

4. Department of Neurosciences, Reproductive Sciences & Odontostomatology, Federico II University, Naples, Italy

Publisher

Future Science Ltd

Subject

Biotechnology

Link

https://www.future-science.com/doi/pdf/10.2144/fsoa-2022-0002

Reference22 articles.

1. Worldwide cancer data. (2021). https://www.wcrf.org/dietandcancer/worldwide-cancer-data

2. New Perspectives in the Therapy of Castration Resistant Prostate Cancer

3. The Evolving Systemic Treatment Landscape for Patients with Advanced Prostate Cancer

4. First-line systemic therapy for metastatic castration-sensitive prostate cancer: An updated systematic review with novel findings

5. Androgen Deprivation Therapy, Hypogonadism and Cardiovascular Toxicity in Men with Advanced Prostate Cancer

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current advances in cancer energy metabolism under dietary restriction: a mini review;Medical Oncology;2024-07-26

2. Cubosomal nanoformulation increase in vitro dissolution and anticancer activity of Fisetin in A549 lung cancer cells;Therapeutic Delivery;2024-04-19

3. Chemopreventive Potential of Dietary Nanonutraceuticals for Prostate Cancer: An Extensive Review;Frontiers in Oncology;2022-07-12

4. Fisetin, a Potent Anticancer Flavonol Exhibiting Cytotoxic Activity against Neoplastic Malignant Cells and Cancerous Conditions: A Scoping, Comprehensive Review;Nutrients;2022-06-23

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3